GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » Cash And Cash Equivalents

CMIC HOLDINGS Co (TSE:2309) Cash And Cash Equivalents : 円11,870 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co Cash And Cash Equivalents?

CMIC HOLDINGS Co's quarterly cash and cash equivalents increased from Jun. 2023 (円12,844.00 Mil) to Sep. 2023 (円19,034.00 Mil) but then stayed the same from Sep. 2023 (円19,034.00 Mil) to Dec. 2023 (円11,870.00 Mil).

CMIC HOLDINGS Co's annual cash and cash equivalents increased from Sep. 2021 (円9,381.00 Mil) to Sep. 2022 (円11,806.00 Mil) and increased from Sep. 2022 (円11,806.00 Mil) to Sep. 2023 (円19,034.00 Mil).


CMIC HOLDINGS Co Cash And Cash Equivalents Historical Data

The historical data trend for CMIC HOLDINGS Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co Cash And Cash Equivalents Chart

CMIC HOLDINGS Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,146.00 12,690.00 9,381.00 11,806.00 19,034.00

CMIC HOLDINGS Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,550.00 14,120.00 12,844.00 19,034.00 11,870.00

CMIC HOLDINGS Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


CMIC HOLDINGS Co  (TSE:2309) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


CMIC HOLDINGS Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


CMIC HOLDINGS Co (TSE:2309) Business Description

Traded in Other Exchanges
N/A
Address
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines